BIORESTORATIVE THERAPIES, INC. (BRTX) Gross margin 2016–2025
BIORESTORATIVE THERAPIES, INC. (BRTX) gross margin by fiscal year — reported gross profit divided by reported revenue.
93.4%FY2025 · since FY2016: 99.7% → 93.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 93.4% | +0.4 pp |
| FY2024 | 93.0% | -7.0 pp |
| FY2023 | 100.0% | — |
| FY2017 | 100.0% | +0.3 pp |
| FY2016 | 99.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BRTX financial trends
BRTX RevenueBRTX Net incomeBRTX Net marginBRTX Gross profitBRTX Operating incomeBRTX Operating marginBRTX Operating cash flowBRTX Free cash flowBRTX Capital expendituresBRTX Return on equityBRTX Stock buybacksBRTX Dividends paidBRTX Total assetsBRTX Total liabilitiesBRTX Shareholders’ equityBRTX overview →